Utah Cannabis
Market Intelligence Report

Utah's medical cannabis program, launched in 2020, has grown steadily into a market generating an estimated $175-176 million in 2025 sales across more than 1.6 million patient transactions. The active patient registry crossed 100,000 for the first time in mid-2025 and has since climbed to 112,093 as of March 2026, with March alone producing $16.3 million in sales — continued momentum in the program's sixth full year.

Utah's program is structurally distinctive in two ways. First, the state charges patients no state or local sales tax on medical cannabis purchases at the point of sale; instead, a 7% Cultivation Privilege Tax is collected upstream when cultivators and processors sell to dispensing pharmacies. Second, the supply chain is unusually concentrated: only 8 licensed cultivators and 15 licensed pharmacies (expanding to as many as 17 under HB54) serve the entire state, with new cultivation licenses issued only if an existing license is forfeited or patient demand outpaces current production caps.

Utah's population of nearly 3.4 million is notably young (median age 32, the lowest of any state in this report set) and has above-median household income, supporting a medical cannabis program that has grown past 112,000 patients. (Official, Census ACS 2024)

Utah's medical cannabis program is regulated jointly by the Department of Health and Human Services' Center for Medical Cannabis (patient registry, pharmacy licensing) and the Department of Agriculture and Food (cultivation and processing licensing). Cultivation licenses are capped at 8 by statute, with new licenses issued only under specific triggering conditions; pharmacy licenses were recently expanded from 15 toward as many as 17 under HB54.

Utah offers a nonrefundable income tax credit to qualifying medical cannabis cultivators, processors, and pharmacies, projected at roughly $1.47 million in aggregate ongoing annual tax savings beginning tax year 2025 — a modest but notable industry-support measure for a medical-only state.

Utah's cannabis supply chain is among the most concentrated of any state in this report set: 8 named cultivators (including Beehive Gardens, Dragonfly Greenhouse, Standard Wellness, and Tryke Companies of Utah) supply 15-17 pharmacies statewide. Cultivation facilities face a 100,000-square-foot production cap each, and the state will only issue new cultivation licenses if an existing license is forfeited or the Department of Health and Human Services certifies that patient demand has outpaced current production. Processing, by contrast, has no statutory license cap, with 14 Tier 1 and 1 Tier 2 processors currently licensed.

Utah's patient base has grown steadily past the 100,000 mark, with monthly sales tracking that growth — March 2026 alone produced $16.3 million across the program's expanding pharmacy network.

Utah's pharmacy network is concentrated along the Wasatch Front (Salt Lake City, Provo, and Ogden metro areas), with additional locations serving more rural regions. The Department of Health and Human Services does not publish a current county-by-county sales breakdown. (Not Available — county-level sales breakdown.)

With cultivation licenses fixed at 8 and pharmacy licenses expanding only modestly under HB54, Utah's cost-to-enter dynamics run largely through the secondary market and through processor licensing, which remains statutorily uncapped.

Vendor demand signal tracks which product and service categories Utah's small, tightly regulated operator base is actively sourcing this quarter.

Utah is unusual among medical-only states in charging patients no state or local sales tax on medical cannabis purchases at the point of sale. Instead, the state collects a 7% Cultivation Privilege Tax levied upstream, on the price at which a cultivator or processor sells to a dispensing pharmacy. The Utah State Tax Commission has not published a separate, itemized total dollar figure for privilege tax revenue collected in FY2025 in publicly available budget documents reviewed for this report. (Not Available — exact privilege tax dollar total.)

Utah is geographically distinctive among medical-only states: it borders four adult-use states (Colorado, Arizona, Nevada, and New Mexico at the Four Corners) and only two states with no comprehensive program (Idaho and Wyoming) — a regional adult-use surround unmatched by any other medical-only state in this report set.

Utah does not publish a consolidated statewide cannabis-industry employment figure. With only 8 cultivators and 15-17 pharmacies statewide, direct industry employment is likely modest relative to states with larger or open license counts, though no official total is available. (Not Available.)

Utah's medical cannabis program does not include a dedicated statewide social equity license track; the fixed cultivator and pharmacy cap structure has limited new-entrant opportunities of any kind since the program's 2020 launch. (Official.)

Utah does not publish an official illicit cannabis market size estimate. With cannabis remaining illegal for adult, non-patient use statewide, and Utah bordered by four adult-use states, some cross-border diversion and unregulated use likely exists, though no official dollar figure quantifies this. (Not Available.)

This report blends official Utah DHHS and UDAF licensing and patient data, state tax code provisions, and reputable cannabis industry media for sales estimates not separately itemized in public budget documents.

This report compiles data from Utah's Department of Health and Human Services, Department of Agriculture and Food, state budget and tax documents, federal demographic sources, and reputable cannabis industry media.